Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Meningitis | Research

Retrospective database analysis for clinical diagnoses commonly associated with pneumococcal diseases in the Malaysian healthcare system over a 3-year period (2013–2015)

Authors: Saravanan S. R. Sundaramurthy, Kristen E. Allen, Mark A. Fletcher, Kok Fui Liew, Boekhtiar Borhanuddin, Mohammad Ali, Graciela Morales, Bradford Gessner, Jerusha Naidoo, Jo Southern

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Pneumococcal disease caused by Streptococcus pneumoniae is an important cause of morbidity and mortality across all ages, particularly in younger children and older adults. Here, we describe pneumococcal disease hospitalizations at Ministry of Health (MoH) facilities in Malaysia between 2013 and 2015.

Methods

This was a retrospective databases analysis. Tabular data from the Malaysian Health Data Warehouse (MyHDW) were used to identify microbiologically confirmed, pneumococcal disease hospitalizations and deaths during hospitalization, using hospital-assigned ICD-10 codes (i.e., classified as meningitis, pneumonia, or non-meningitis non-pneumonia). Case counts, mortality counts, and case fatality rates were reported by patient age group and by Malaysian geographic region.

Results

A total of 683 pneumococcal disease hospitalizations were identified from the analysis: 53 pneumococcal meningitis hospitalizations (5 deaths and 48 discharges), 413 pneumococcal pneumonia hospitalizations (24 deaths and 389 discharges), and 205 non-meningitis non-pneumonia pneumococcal disease hospitalizations (58 deaths and 147 discharges). Most hospitalizations occurred in children aged < 2 years. Crude mortality was highest among children aged < 2 years (for all three disease categories), among adults aged ≥ 65 years (for pneumococcal pneumonia), or among adults aged 65–85 years (for non-meningitis non-pneumonia pneumococcal disease). The case fatality rate, all ages included, was 5.8% for pneumococcal pneumonia, 9.1% for pneumococcal meningitis, and 28.3% for non-meningitis non-pneumonia pneumococcal disease.

Conclusions

Our study is the first to document pneumococcal disease hospitalizations and deaths during hospitalization in Malaysia. Although this database analysis likely underestimated case counts, and the true disease burden could be even greater, the study demonstrates a substantial burden of pneumococcal disease. Public health measures, including vaccination, would significantly contribute to the prevention of hospitalizations and deaths associated with pneumococcal disease in Malaysia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chavez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(53):795.CrossRefPubMed Chavez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(53):795.CrossRefPubMed
2.
go back to reference Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I, Black RE, Lancet D. Pneumonia Interventions Study G: Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381(9875):1417–29.CrossRefPubMed Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I, Black RE, Lancet D. Pneumonia Interventions Study G: Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381(9875):1417–29.CrossRefPubMed
3.
go back to reference Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Luksic I, Nair H, McAllister DA, Campbell H, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–57.CrossRefPubMedPubMedCentral Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Luksic I, Nair H, McAllister DA, Campbell H, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–57.CrossRefPubMedPubMedCentral
4.
go back to reference Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–16.CrossRefPubMedPubMedCentral Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–16.CrossRefPubMedPubMedCentral
5.
go back to reference Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O’Brien KL, Campbell H, Black RE. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381(9875):1405–16.CrossRefPubMedPubMedCentral Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O’Brien KL, Campbell H, Black RE. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381(9875):1405–16.CrossRefPubMedPubMedCentral
6.
go back to reference Wu DB, Roberts CS, Huang YC, Chien L, Fang CH, Chang CJ. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan. J Med Econ. 2014;17(5):312–9.CrossRefPubMed Wu DB, Roberts CS, Huang YC, Chien L, Fang CH, Chang CJ. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan. J Med Econ. 2014;17(5):312–9.CrossRefPubMed
7.
go back to reference Casez P, Fauconnier J, Jorgensen L, Gutterman EM, Gray S, Munson S, Dartois N, Gaillat J. Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Med Mal Infect. 2015;45(11–12):446–55.CrossRefPubMed Casez P, Fauconnier J, Jorgensen L, Gutterman EM, Gray S, Munson S, Dartois N, Gaillat J. Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Med Mal Infect. 2015;45(11–12):446–55.CrossRefPubMed
8.
go back to reference Zhang D, Petigara T, Yang X. Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study. BMC Infect Dis. 2018;18(1):436.CrossRefPubMedPubMedCentral Zhang D, Petigara T, Yang X. Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study. BMC Infect Dis. 2018;18(1):436.CrossRefPubMedPubMedCentral
9.
go back to reference Yu O, Nelson JC, Bounds L, Jackson LA. Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data. Epidemiol Infect. 2011;139(9):1296–306.CrossRefPubMed Yu O, Nelson JC, Bounds L, Jackson LA. Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data. Epidemiol Infect. 2011;139(9):1296–306.CrossRefPubMed
10.
go back to reference Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia (Nathan). 2021;13(1):9.CrossRefPubMed Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia (Nathan). 2021;13(1):9.CrossRefPubMed
11.
go back to reference Zainel AH, Mitchell H, Sadarangani M. Bacterial Meningitis in Children: Neurological Complications, Associated Risk Factors, and Prevention. Microorganisms. 2021;9(3):535.CrossRefPubMedPubMedCentral Zainel AH, Mitchell H, Sadarangani M. Bacterial Meningitis in Children: Neurological Complications, Associated Risk Factors, and Prevention. Microorganisms. 2021;9(3):535.CrossRefPubMedPubMedCentral
12.
go back to reference Anh DD, Kilgore PE, Slack MP, Nyambat B, le Tho H, Yoshida LM, Nguyen HA, Nguyen CD, Chong CY, Nguyen D, et al. Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province Vietnam. Clin Infect Dis. 2009;48(Suppl 2):S57-64.CrossRefPubMed Anh DD, Kilgore PE, Slack MP, Nyambat B, le Tho H, Yoshida LM, Nguyen HA, Nguyen CD, Chong CY, Nguyen D, et al. Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province Vietnam. Clin Infect Dis. 2009;48(Suppl 2):S57-64.CrossRefPubMed
13.
go back to reference Wahl B, Sharan A, Deloria Knoll M, Kumar R, Liu L, Chu Y, McAllister DA, Nair H, Campbell H, Rudan I, et al. National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000–15. Lancet Glob Health. 2019;7(6):e735–47.CrossRefPubMedPubMedCentral Wahl B, Sharan A, Deloria Knoll M, Kumar R, Liu L, Chu Y, McAllister DA, Nair H, Campbell H, Rudan I, et al. National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000–15. Lancet Glob Health. 2019;7(6):e735–47.CrossRefPubMedPubMedCentral
14.
go back to reference Bravo LC. Asian Strategic Alliance for Pneumococcal Disease Prevention Working G: Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine. 2009;27(52):7282–91.CrossRefPubMed Bravo LC. Asian Strategic Alliance for Pneumococcal Disease Prevention Working G: Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine. 2009;27(52):7282–91.CrossRefPubMed
15.
go back to reference Rhodes J, Dejsirilert S, Maloney SA, Jorakate P, Kaewpan A, Salika P, Akarachotpong T, Prapasiri P, Naorat S, Areerat P, et al. Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand: An Update on Incidence, Clinical Characteristics, Serotype Distribution, and Antimicrobial Susceptibility, 2005–2010. PLoS ONE. 2013;8(6):e66038.CrossRefPubMedPubMedCentral Rhodes J, Dejsirilert S, Maloney SA, Jorakate P, Kaewpan A, Salika P, Akarachotpong T, Prapasiri P, Naorat S, Areerat P, et al. Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand: An Update on Incidence, Clinical Characteristics, Serotype Distribution, and Antimicrobial Susceptibility, 2005–2010. PLoS ONE. 2013;8(6):e66038.CrossRefPubMedPubMedCentral
16.
go back to reference Piralam B, Tomczyk SM, Rhodes JC, Thamthitiwat S, Gregory CJ, Olsen SJ, Praphasiri P, Sawatwong P, Naorat S, Chantra S, et al. Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006–2011: Implications for Pneumococcal Vaccine Considerations. Am J Trop Med Hyg. 2015;93(6):1140–7.CrossRefPubMedPubMedCentral Piralam B, Tomczyk SM, Rhodes JC, Thamthitiwat S, Gregory CJ, Olsen SJ, Praphasiri P, Sawatwong P, Naorat S, Chantra S, et al. Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006–2011: Implications for Pneumococcal Vaccine Considerations. Am J Trop Med Hyg. 2015;93(6):1140–7.CrossRefPubMedPubMedCentral
17.
go back to reference Hung IF, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013;17(6):e364-373.CrossRefPubMed Hung IF, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013;17(6):e364-373.CrossRefPubMed
18.
go back to reference Rohani MY, Raudzah A, Ng AJ, Ng PP, Zaidatul AA, Asmah I, Murtaza M, Parasakthy N, Mohd Yasmin MY, Cheong YM. Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect. 1999;122(1):77–82.CrossRefPubMedPubMedCentral Rohani MY, Raudzah A, Ng AJ, Ng PP, Zaidatul AA, Asmah I, Murtaza M, Parasakthy N, Mohd Yasmin MY, Cheong YM. Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect. 1999;122(1):77–82.CrossRefPubMedPubMedCentral
19.
go back to reference Aljunid S, Abuduxike G, Ahmed Z, Sulong S, Nur AM, Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infect Dis. 2011;11:248.CrossRefPubMedPubMedCentral Aljunid S, Abuduxike G, Ahmed Z, Sulong S, Nur AM, Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infect Dis. 2011;11:248.CrossRefPubMedPubMedCentral
20.
go back to reference Arushothy R, Ahmad N, Amran F, Hashim R, Samsudin N, Azih CRC. Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: A four-year study (2014–2017) on invasive paediatric isolates. Int J Infect Dis. 2019;80:129–33.CrossRefPubMed Arushothy R, Ahmad N, Amran F, Hashim R, Samsudin N, Azih CRC. Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: A four-year study (2014–2017) on invasive paediatric isolates. Int J Infect Dis. 2019;80:129–33.CrossRefPubMed
21.
go back to reference Dzaraly ND, Mohd Desa MN, Muthanna A, Masri SN, Taib NM, Suhaili Z, Sulaiman N, Baharin NHZ, Shuan CY, Ariffin Z, et al. Antimicrobial susceptibility, serotype distribution, virulence profile and molecular typing of piliated clinical isolates of pneumococci from east coast, Peninsular Malaysia. Sci Rep. 2021;11(1):8220.CrossRefPubMedPubMedCentral Dzaraly ND, Mohd Desa MN, Muthanna A, Masri SN, Taib NM, Suhaili Z, Sulaiman N, Baharin NHZ, Shuan CY, Ariffin Z, et al. Antimicrobial susceptibility, serotype distribution, virulence profile and molecular typing of piliated clinical isolates of pneumococci from east coast, Peninsular Malaysia. Sci Rep. 2021;11(1):8220.CrossRefPubMedPubMedCentral
22.
go back to reference Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine. 2012;30(24):3503–14.CrossRefPubMed Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine. 2012;30(24):3503–14.CrossRefPubMed
23.
go back to reference Jefferies JM, Mohd Yusof MY, Devi Sekaran S, Clarke SC. Novel clones of Streptococcus pneumoniae causing invasive disease in Malaysia. PLoS ONE. 2014;9(6):e97912.CrossRefPubMedPubMedCentral Jefferies JM, Mohd Yusof MY, Devi Sekaran S, Clarke SC. Novel clones of Streptococcus pneumoniae causing invasive disease in Malaysia. PLoS ONE. 2014;9(6):e97912.CrossRefPubMedPubMedCentral
24.
go back to reference Kim SH, Chung DR, Song JH, Baek JY, Thamlikitkul V, Wang H, Carlos C, Ahmad N, Arushothy R, Tan SH, et al. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes. Vaccine. 2020;38(38):6065–73.CrossRefPubMed Kim SH, Chung DR, Song JH, Baek JY, Thamlikitkul V, Wang H, Carlos C, Ahmad N, Arushothy R, Tan SH, et al. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes. Vaccine. 2020;38(38):6065–73.CrossRefPubMed
25.
go back to reference Le CF, Palanisamy NK, Mohd Yusof MY, Sekaran SD. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia. PLoS ONE. 2011;6(5):e19547.CrossRefPubMedPubMedCentral Le CF, Palanisamy NK, Mohd Yusof MY, Sekaran SD. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia. PLoS ONE. 2011;6(5):e19547.CrossRefPubMedPubMedCentral
26.
go back to reference Yasin RM, Zin NM, Hussin A, Nawi SH, Hanapiah SM, Wahab ZA, Raj G, Shafie N, Peng NP, Chu KK, et al. Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine. 2011;29(34):5688–93.CrossRefPubMed Yasin RM, Zin NM, Hussin A, Nawi SH, Hanapiah SM, Wahab ZA, Raj G, Shafie N, Peng NP, Chu KK, et al. Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine. 2011;29(34):5688–93.CrossRefPubMed
27.
go back to reference Bollaerts K, Fletcher MA, Suaya JA, Hanquet G, Baay M, Gessner BD. Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials. Clin Infect Dis. 2022;74(8):1362–71.CrossRefPubMed Bollaerts K, Fletcher MA, Suaya JA, Hanquet G, Baay M, Gessner BD. Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials. Clin Infect Dis. 2022;74(8):1362–71.CrossRefPubMed
28.
go back to reference WHO. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine. 2012;30(32):4717–8.CrossRef WHO. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine. 2012;30(32):4717–8.CrossRef
Metadata
Title
Retrospective database analysis for clinical diagnoses commonly associated with pneumococcal diseases in the Malaysian healthcare system over a 3-year period (2013–2015)
Authors
Saravanan S. R. Sundaramurthy
Kristen E. Allen
Mark A. Fletcher
Kok Fui Liew
Boekhtiar Borhanuddin
Mohammad Ali
Graciela Morales
Bradford Gessner
Jerusha Naidoo
Jo Southern
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08611-3

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine